Bee Vectoring Technologies Announces Higher US Grower Sales Commitments for 2022 Despite Adverse Conditions; Sales Activities Continue to Grow Across the US Pacific Coast

Press Releases
Posted on April 20, 2022

Bee Vectoring Technologies Announces Higher US Grower Sales Commitments for 2022 Despite Adverse Conditions; Sales Activities Continue to Grow Across the US Pacific Coast

Mississauga, ON Canada and Sacramento, CA USA (April 20, 2022) – Bee Vectoring Technologies International Inc. (the “Company” or “BVT”) (CSE: BEE) (OTCQB: BEVVF) (CVE:BEE) is pleased to announce positive progress in 2022 sales commitments from US growers. In just seven months into the fiscal year, the Company has invoiced growers in the Southeast region and secured commitments in the Northeast, Midwest, and Pacific Northwest – already increasing total sales year-over-year by 18%.

“We’ve already increased sales year-over-year and are committed to growing them even further before each region’s blooming period,” said Ian Collinson, Sales Manager at BVT. “This includes activity for additional acres that our Pacific Coast sales team is working aggressively to secure. This region is responsible for the production of one-third of all blueberries grown in the United States and we are in active discussions with some of the USA’s largest berry growers. This, in the long run, represents a bigger opportunity for us compared to the Southeast.”

These positive results have been accomplished despite a very difficult farming environment in most regions. Volatile supply costs have seen fertilizer prices double over last year in several cases, and prices of fuel and other chemical products necessary to run farming operations have increased by up to 40%.

“Farmers are being squeezed harder than ever and they have had to make tough choices on which products to invest in to help their crops thrive this year,” said Ashish Malik, CEO of BVT. “Already achieving year-over-year sales increases for BVT, with several months still to go, is a testament to the strength and efficacy of our natural precision agriculture system and proprietary Clonostachys rosea CR-7 (CR-7) biological fungicide.”

Furthermore, in Georgia, the Company’s largest market last year, growers faced severe weather and hard freezes during the blueberry bloom period and this has had an impact on BVT sales as several growers have unfortunately experienced a partial or complete crop loss.

“Despite these extreme weather events, coupled with the dramatic rise in fertilizer, chemical and fuel costs, BVT has successfully retained the same level of sales year-over-year in Georgia,” said Everett Hendrixon, BVT’s Territory Manager for the US Southeast. “I have talked to my peers with other ag suppliers, and they are sharing the same stories about the difficult conditions for our grower clients. Some of them have lost significant quantity, meaning their sales orders are dramatically lower than the previous year.”

“Increasing share of planted acres in such a challenging environment, which can periodically occur in agricultural markets, means that increasingly, more growers are seeing the value in our technology. We look forward to continued growth in 2022 and are even more excited about BVT’s opportunities in a more normalized business environment,” continued Mr. Malik.

About Bee Vectoring Technologies International Inc.

BVT, an agriculture technology company, is a market disruptor with a significant global market opportunity in the $240 billion crop protection and fertilizer market. BVT has pioneered a natural precision agriculture system that replaces chemical pesticides and wasteful plant protection product spray applications by delivering biological pesticide alternatives to crops using commercially grown bees. BVT’s award-winning technology, precision vectoring, is completely harmless to bees and allows minute amounts of naturally-derived pesticides (called biologicals) to be delivered directly to blooms, providing improved crop protection and yield results than traditional chemical pesticides – and improving the health of the soil, the microbiome and the environment. Currently, BVT has over 65 granted patents, over 35 patents pending in all major agricultural countries worldwide and has US EPA registration of its Vectorite™ with CR-7 (EPA Registration No. 90641-2) for sale as a registered biological fungicide for use on the labeled crops.

Additional information can be viewed at the Company’s website To receive regular news updates from the Company, subscribe at

Company Contact:
Ashish Malik, President & CEO

Investor Contact:
Babak Pedram, Investor Relations
Virtus Advisory Group
Tel: 416-995-8651

The CSE has neither approved nor disapproved the contents of this press release. The CSE does not accept responsibility for the adequacy or accuracy of this release. Certain statements contained in this press release constitute “forward-looking information” as such term is defined in applicable Canadian securities legislation. The words “may”, “would”, “could”, “should”, “potential”, “will”, “seek”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” and similar expressions as they relate to the Company, “annual revenue potential”, are intended to identify forward-looking information. All statements other than statements of historical fact may be forward-looking information. Such statements reflect the Company’s current views and intentions with respect to future events, and current information available to the Company, and are subject to certain risks, uncertainties and assumptions, including: planted acres, selling price of competitive chemical pesticides and the US to Canadian dollar exchange rate. Material factors or assumptions were applied in providing forward-looking information. Many factors could cause the actual results, performance or achievements that may be expressed or implied by such forward-looking information to vary from those described herein should one or more of these risks or uncertainties materialize. These factors include changes in law, competition, litigation, the ability to implement business strategies and pursue business opportunities, state of the capital markets, the availability of funds and resources to pursue operations, new technologies, the ability to protect intellectual property rights, the ability to obtain patent protection for products, third-party intellectual property infringement claims, regulatory changes affecting products, failing research and development activities, the ability to reach and sustain profitability, dependence on business and technical experts, the ability to effectively manage business operations and growth, issuance of debt, dilution of existing securities, volatility of publicly traded securities, potential conflicts of interest, unlikelihood of dividend payments, the potential costs stemming from defending third-party intellectual property infringement claims, the ability to secure relationships with manufacturers and purchasers, as well as general economic, market and business conditions, as well as those risk factors discussed or referred to in the Company’s Filing Statement dated August 14,2020, filed with the CSE and securities regulatory authorities in certain provinces of Canada and available at Should any factor affect the Company in an unexpected manner, or should assumptions underlying the forward-looking information prove incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-looking information is expressly qualified in its entirety by this cautionary statement. Moreover, the Company does not assume responsibility for the accuracy or completeness of such forward-looking information. The forward-looking information included in this press release is made as of the date of this press release and the Company undertakes no obligation to publicly update or revise any forward-looking information, other than as required by applicable law. All figures are in Canadian dollars.